AES
55
-3
GPC
61
-5
DD
55
-4
PSX
39
-3
PVH
44
-4
TRIP
57
-4
NKE
43
-6
HIG
56
-2
IP
31
-6
EQT
50
-4
AMT
37
-2
BLK
61
-5
SRE
54
-5
PG
43
3
ROP
38
-10
HOG
35
-3
AMAT
49
-6
PEG
50
-3
LNC
70
-5
PPL
62
5
AES
55
-3
GPC
61
-5
DD
55
-4
PSX
39
-3
PVH
44
-4
TRIP
57
-4
NKE
43
-6
HIG
56
-2
IP
31
-6
EQT
50
-4
AMT
37
-2
BLK
61
-5
SRE
54
-5
PG
43
3
ROP
38
-10
HOG
35
-3
AMAT
49
-6
PEG
50
-3
LNC
70
-5
PPL
62
5
Financhill
Back

Compagnie de Saint-Gobain SA Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
55

CODYY
Compagnie de Saint-Gobain SA

Last Price:
$20.31
Seasonality Move:
4.91%
Sell
39

MNPR
Monopar Therapeutics, Inc.

Last Price:
$74.46
Seasonality Move:
36.18%
Buy
55
Compagnie de Saint-Gobain SA (CODYY) is a Buy

Is Compagnie de Saint-Gobain SA a Buy, Sell or Hold?

  • The current Compagnie de Saint-Gobain SA [CODYY] share price is $20.31. The Score for CODYY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CODYY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CODYY Stock Price Chart

What is Compagnie de Saint-Gobain SA's stock price today?

  • The Compagnie de Saint-Gobain SA share price today is $20.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CODYY is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $74.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

CODYY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 57.07 Buy
Chaikin Money Flow: -54234 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.8 - 19.98) Buy
Bollinger Bands (100): (19.64 - 22.52) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.71 Sell
Relative Strength Index (14 RSI): 41.23 Sell
Chaikin Money Flow: -100149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.75 - 86.63) Sell
Bollinger Bands (100): (43.73 - 88.49) Buy

CODYY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.89 Buy
20-day SMA: 19.47 Buy
50-day SMA: 19.93 Buy
200-day SMA: 21.49 Sell
8-day EMA: 19.95 Buy
20-day EMA: 19.72 Buy
50-day EMA: 20.04 Buy
200-day EMA: 20.64 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.35 Sell
20-day SMA: 81.26 Sell
50-day SMA: 84.43 Sell
200-day SMA: 51.38 Buy
8-day EMA: 77.66 Sell
20-day EMA: 80.1 Sell
50-day EMA: 78.38 Sell
200-day EMA: 56.01 Buy

Compagnie de Saint-Gobain SA Earnings Growth & CODYY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Compagnie de Saint-Gobain SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):